In the case of SIRT3, no cellular activity has been reported for the most potent inhibitors identified so far (29a,b and 30),376, 377 while anticancer activity has been reported only for the amino acid derivative 31 in head and neck squamous cell carcinoma lines.378. Here, SIRT3 is linked to head and neck squamous cell carcinoma.